Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2020 06:10 ET | Source: Coloplast A/S

Coloplast A/S - Announcement no. 11/2020 – Annual Report 2019/20 & Remuneration Report 2019/20

Financial highlights of the year Organic growth for the full year was 4% and reported revenue in DKK increased by 3% to DKK 18,544 million.Organic growth rates by business area for the financial...
November 03, 2020 06:10 ET | Source: Coloplast A/S

Coloplast A/S - 11/2020 - Årsrapport 2019/20 & Vederlagsrapport 2019/20

Årets resultat i hovedpunkter Den organiske omsætningsvækst for hele året var 4%, og den rapporterede omsætning målt i danske kroner steg 3% til 18.544 mio. kr.Den organiske vækst fordelt på...
November 03, 2020 06:04 ET | Source: Coloplast A/S

Coloplast acquires Nine Continents Medical, Inc.

Coloplast announced today that it has completed the acquisition of Nine Continents Medical, Inc., an early stage company pioneering an implantable tibial nerve stimulation treatment for over-active...
November 03, 2020 06:04 ET | Source: Coloplast A/S

Coloplast køber Nine Continents Medical, Inc.

Coloplast har i dag meddelt, at selskabet har købt Nine Continents Medical, Inc., et selskab i et tidligt stadie, som har udviklet et implantabelt produkt til stimulation af tibialnerven til...
November 03, 2020 06:02 ET | Source: Coloplast A/S

Coloplast leverer solidt årsregnskab på trods af COVID-19-pandemien og forventer 7-8% organisk vækst og en overskudsgrad på 31-32% i 2020/21

Coloplast leverede en organisk omsætningsvækst på 4% i regnskabsåret 2019/20, og driftsresultatet steg 5%, svarende til en overskudsgrad på 32%. Virksomheden har lanceret en ny koncernstrategi,...
November 03, 2020 06:02 ET | Source: Coloplast A/S

Coloplast delivers solid full year results despite the COVID-19 pandemic and expects 7-8% organic growth and 31-32% EBIT margin for 2020/21

Coloplast delivered 4% organic revenue growth in the 2019/20 financial year and a 5% increase in EBIT corresponding to an EBIT margin of 32%. The company has launched a new corporate strategy called...
November 03, 2020 06:00 ET | Source: Coloplast A/S

Coloplast A/S - Announcement no. 10/2020 - Full-year Financial Results 2019/20

2019/20Announcement of full-year financial results 2019/20(01 October 2019 - 30 September 2020) Back to organic growth in Q4 2019/20. In 2020/21 we expect 7-8% organic growth and 31-32% EBIT...
November 03, 2020 06:00 ET | Source: Coloplast A/S

Coloplast A/S - Selskabsmeddelelse nr. 10/2020 - Årsregnskabsmeddelelse 2019/20

2019/20 Årsregnskabsmeddelelse 2019/20(1. oktober 2019 – 30. september 2020) Tilbage til organisk vækst i fjerde kvartal 2019/20. I 2020/21 forventes en...
September 29, 2020 09:00 ET | Source: Coloplast A/S

Coloplast gennemfører minoritetsinvestering i Francis Medical

Coloplast har i dag annonceret, at selskabet har gennemført en aktieinvestering på 4 mio. USD (25 mio. kr.) i Francis Medical, der er en ung virksomhed, som udvikler terapier til behandling af...
September 29, 2020 09:00 ET | Source: Coloplast A/S

Coloplast completes minority investment in Francis Medical

Coloplast announced today that it has completed a USD 4m (DKK 25m) equity investment in Francis Medical, an early stage company pioneering urological cancer treatments, beginning with prostate...